Viewing Study NCT01446159


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-07-03 @ 1:12 AM
Study NCT ID: NCT01446159
Status: COMPLETED
Last Update Posted: 2020-06-02
First Post: 2011-09-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Sponsor: MedImmune LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF View